Register Now: The Physiology Course, June 5-6, 2025

The latest research and advancements in coronary physiology

The Minneapolis Heart Institute Foundation® (MHIF) and Allina Health Minneapolis Heart Institute®, in partnership with CoreAalst®, Optima®, and The American College of Cardiology – Minnesota Chapter®, are pleased to present The Physiology Course. Join us as we explore how to use coronary physiology for the assessment of epicardial coronary artery disease and the coronary microcirculation. This educational opportunity is an in-person experience that includes presentations, debates, discussions, hands-on training, and interactive live cases.

Dates: June 5-6, 2025
Location: MacMillan Center | 2800 10th Ave S, Minneapolis, MN

Our expert faculty will delve into the latest research and advancements in coronary physiology, including wire-based and wireless approaches, providing valuable insights for cardiovascular professionals and researchers alike to improve patient care. Don’t miss the opportunity to join this inaugural coronary physiology course in the United States and deepen your understanding of the vital role that coronary physiology plays in modern PCI and the assessment of patients with coronary microvascular dysfunction.

Course Directors

  • Yader Sandoval, MD, FACC, FSCAI, FESC
  • Emmanouil Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI
  • Carlos Collet, MD, PhD
  • Bernard De Bruyne, MD, PhD

Faculty

  • João Cavalcante, MD, FACC, FASE, FSCCT, FSCMR
  • William Fearon, MD
  • Nils P. Johnson, MD, MS
  • Morton J. Kern, MD
  • Claire E. Raphael, MBBS, PhD
  • Arnold Seto, MD, MPA
  • Nathaniel R. Smilowitz, MD
  • Jay Traverse, MD
  • R. Jay Widmer, MD, PhD

Serious Illness Conversations: Improving Patient Care at End of Life

Closeup photograph of doctor talking to patients

When patients are experiencing serious illness—and perhaps approaching end of life—combining your medical skills with a solid understanding of what is important to your patients allows you to plan for the best care possible, together.

Sometimes this can be more challenging than it seems but, like other skills, how to gain this understanding can be learned, and your skills will improve over time with practice and support. The Center for Advancing Serious Illness Communication (CASIC) will provide you with the training, skills and resources to help you provide the highest quality of care for your patients by ensuring the care you deliver is concordant with your patient’s goals.

A joint project of the Minnesota Medical Association and the Minnesota Hospital Association, CASIC’s comprehensive training series will introduce you to serious illness communication and to the Serious Illness Conversation Guide (SICG). This evidence-based, patient tested tool was developed by Ariadne Labs, a joint center for health systems innovation at Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health.

This no-cost, CME-eligible training is available to members of care teams who work with patients with serious illnesses. First, you’ll take a prerequisite sequence of three on-demand, online modules, accessed here: www.advancingsic.org/training-and-events

Part 1: Serious Illness Conversation—An Introduction (.25 credit)
Part 2: The Serious Illness Conversation Guide (.5 credit)
Part 3: Implementing Serious Illness Communication (.25 credit)

Upon completion of the modules, you’ll take part in a live, virtual three hour classroom training session, qualifying for 3 AMA PRA Category 1 credits, where you will:

  • Experience the Serious Illness Conversation Guide as part of a structured approach for ensuring the delivery of serious illness conversations.
  • Practice the communication skills necessary to use the Serious Illness Conversation Guide, receive feedback to improve those skills, and integrate these skills into your practice.

Please visit www.advancingsic.org/training-and-events to learn about our upcoming classroom training dates and to register.

Poster Deadline EXTENDED to Friday Jan. 31 for Midwest WIC Symposium

The 2025 Midwest WIC Symposium’s Poster Contest is open for submissions!

CV Team members, Fellows in Training, Residents & Medical Students are welcome to submit research or case studies for consideration by January 31, 2025. There will be an award for first, second, and third place in each category.

Presenters will be judged on the following criteria: originality, scientific content, presentation and answer to questions raised by the case. Winners will be announced on-site at the 2025 Midwest WIC Symposium.

Read more on the Poster Contest web page.

Midwest WIC Symposium Registration Now Open

Make plans to join us on Saturday, March 1st at the Red Rock Casino Resort & Spa in Las Vegas, Nevada for the 8th annual Midwest ACC Women in Cardiology (WIC) Symposium.

The Midwest ACC WIC Symposium aims to share knowledge and best practices with all clinicians who care for female patients to improve the overall cardiovascular health of women. Physicians, Fellows in Training, CV team members and Poster Contest presenters are welcome to register online.

Save the Date: 2025 Midwest WIC Symposium

Mark your calendar and make plans to join us on Saturday, March 1st at the Red Rock Casino Resort & Spa in Las Vegas, NV.

The Midwest ACC Women in Cardiology (WIC) Symposium aims to share knowledge and best practices with all clinicians who care for female patients to improve the overall cardiovascular health of women. Physicians, Fellows in Training, CV team members and Poster Contest presenters are welcome to attend.

ACC.25 Annual Scientific Session

The cardiology world reunites at ACC.25, March 29 – 31, 2025 in Chicago, IL. At ACC.25 you’ll have the opportunity to connect with your colleagues from around the world, explore the latest science and innovation, and gain valuable insights into practice-changing updates in care. The transformation of cardiovascular care for all starts here!

Read more.

Register Today: 2024 Midwest CV Forum

Join us October 26-27 at the Omni Viking Lakes in Eagan, MN! The annual Midwest Cardiovascular Forum is a 1.5-day conference exploring the latest in cardiology. Sessions include topics for seasoned cardiologists, fellows-in-training, and cardiovascular team members.

Read more.

This event is presented in collaboration with the ACC Great Plains and Iowa Chapters.

Register Now: Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Photograph of black stethoscope and red heart toy against an orange background

Register now for this upcoming educational webinar.

Learning Objectives:

  1. Review cardiac amyloidosis and its pathogenesis, subtypes, prevalence and the importance of identification of ATTR-CM.
  2. Identify signs, symptoms and modalities used for screening for ATTR-CM in everyday practice.
  3. Discuss the Multi-Societal Expert Consensus Recommendations (MECR) on imaging cardiac amyloidosis and describe the role of echocardiography, cardiovascular magnetic resonance (CMR) and nuclear scintigraphy in diagnosing and typing of patients with suspected or known cardiac amyloidosis.
  4. Review and discuss a patient case study.

Speaker:

Tamara S. Evans, BS, Pharm.D., MPH, PAHM
Senior Medical Director, Pfizer Inc
US Medical Affairs, Rare Cardiology

Webinar: Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Photograph of black stethoscope and red heart toy against an orange background

Title: Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Disease Overview, Image Findings, and Case Study

1. Review cardiac amyloidosis and its pathogenesis, subtypes, prevalence and the importance of identification of ATTR-CM.

2. Identify signs, symptoms and modalities used for screening for ATTR-CM in everyday practice.

3. Discuss the Multi-Societal Expert Consensus Recommendations (MECR) on imaging cardiac amyloidosis and describe the role of echocardiography, cardiovascular magnetic resonance (CMR) and nuclear scintigraphy in diagnosing and typing of patients with suspected or known cardiac amyloidosis.

4. Review and discuss a patient case study.

Presented by:
Tamara S. Evans, BS, Pharm.D., MPH, PAHM
Senior Medical Director, Pfizer Inc
US Medical Affairs, Rare Cardiology
1 2 3 4 5 8